Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Parkinson disease	20/249	3.17878172049763E-12	7.406561408759478E-10	0	0	8.758705632068077	231.88255457617598	CAMK2B;TUBB;TUBB4B;TUBB4A;GNAI1;GNAI2;UCHL1;PSMA3;TUBB2B;PSMC5;TUBA1A;TUBB2A;PSMC6;PSMB2;KIF5C;TUBB3;PSMC2;MAPT;SLC25A5;UBA52
Pathways of neurodegeneration	25/475	6.30498694761606E-11	7.34530979397271E-9	0	0	5.6535087719298245	132.7844983088963	CAMK2B;GSK3B;UCHL1;PPP3CB;ACTR1A;TUBA1A;PSMB2;KIF5C;TUBB3;NEFL;SPTBN2;TUBB;TUBB4B;TUBB4A;PSMA3;TUBB2B;PSMC5;TUBB2A;PSMC6;GNAQ;PSMC2;KRAS;MAPT;SLC25A5;UBA52
Gap junction	12/88	1.7549197839091976E-10	1.3629876988361436E-8	0	0	15.329789992221935	344.3596303918758	TJP1;TUBB2B;TUBA1A;TUBB2A;TUBB3;TUBB;GNAQ;KRAS;TUBB4B;TUBB4A;GNAI1;GNAI2
Alzheimer disease	21/369	5.743218448914389E-10	3.308548002347329E-8	0	0	6.045991823675791	128.64559328759478	GSK3B;TUBB;TUBB4B;TUBB4A;RTN4;PPP3CB;PSMA3;TUBB2B;PSMC5;TUBA1A;TUBB2A;PSMC6;PSMB2;KIF5C;TUBB3;GNAQ;PSMC2;KRAS;MAPT;SLC25A5;GAPDH
Synaptic vesicle cycle	11/78	7.099888417054353E-10	3.308548002347329E-8	0	0	15.869037167105649	334.2935166306486	NSF;DNM3;SNAP25;STX1B;STXBP1;CLTC;ATP6V1B2;ATP6V1H;DNM1;VAMP2;ATP6V0A1
Axon guidance	15/182	1.2568378707004311E-9	4.880720397886675E-8	0	0	8.810479041916167	180.56783316532994	CAMK2B;GSK3B;DCC;L1CAM;MYL12A;GNAI1;GNAI2;CDC42;PPP3CB;DPYSL5;DPYSL2;PLXNA1;KRAS;NEO1;PLXNA4
Salmonella infection	17/249	1.7678438044634355E-9	5.884394377714006E-8	0	0	7.236176419366075	145.83431925880942	AHNAK;TUBB;CSE1L;TUBB4B;TUBB4A;MYL12A;RHOB;CDC42;ACTR1A;TUBB2B;TUBA1A;TUBB2A;KIF5C;TUBB3;ARPC3;GAPDH;PFN2
Prion disease	17/273	7.08392360074071E-9	2.0631927487157318E-7	0	0	6.549735637626263	122.9086573813881	GSK3B;TUBB;TUBB4B;TUBB4A;PPP3CB;PSMA3;TUBB2B;PSMC5;TUBA1A;TUBB2A;PSMC6;PSMB2;KIF5C;TUBB3;PSMC2;NCAM1;SLC25A5
Pathogenic Escherichia coli infection	14/197	3.0267847284055124E-8	7.836009352427604E-7	0	0	7.460729141179349	129.1689453109107	TUBB;MYO5A;TUBB4B;TUBB4A;TJP1;CDC42;TUBB2B;TUBA1A;TUBB2A;TUBB3;ARPC3;MYH9;ARHGEF2;GAPDH
Huntington disease	17/306	3.817702870952089E-8	8.895247689318367E-7	0	0	5.792038027332145	98.93398599170672	TUBB;CLTC;TUBB4B;TUBB4A;ACTR1A;PSMA3;TUBB2B;PSMC5;TUBA1A;TUBB2A;PSMC6;PSMB2;KIF5C;TUBB3;GNAQ;PSMC2;SLC25A5
Dopaminergic synapse	11/132	1.9040224374150015E-7	4.033065708342685E-6	0	0	8.762923351158646	135.59858821633594	CAMK2B;PPP1CC;GSK3B;PPP3CB;KIF5C;PPP2R5E;GNAQ;PPP2R2A;COMT;GNAI1;GNAI2
Amyotrophic lateral sclerosis	17/364	4.542667809251607E-7	8.820346662963537E-6	0	0	4.809565394579804	70.24168828560188	TUBB;TUBB4B;TUBB4A;PPP3CB;ACTR1A;PSMA3;TUBB2B;PSMC5;TUBA1A;TUBB2A;PSMC6;PSMB2;KIF5C;TUBB3;PSMC2;NEFL;PFN2
Adrenergic signaling in cardiomyocytes	11/150	6.918444234721989E-7	1.2399980820694028E-5	0	0	7.621173649315842	108.0980009587879	CAMK2B;PPP1CC;ACTC1;PPP2R5E;GNAQ;TPM1;ATP1A3;PPP2R2A;ATP1B1;GNAI1;GNAI2
Phagosome	10/152	5.943388726828977E-6	9.891496952508226E-5	0	0	6.747852971487461	81.1984741977972	TUBB2B;TUBA1A;TUBB2A;TUBB3;TUBB;ATP6V1B2;ATP6V1H;TUBB4B;TUBB4A;ATP6V0A1
Endocrine and other factor-regulated calcium reabsorption	6/53	2.167905506376846E-5	3.367479886572034E-4	0	0	12.056194645220401	129.47345112469029	DNM3;GNAQ;CLTC;ATP1A3;ATP1B1;DNM1
Epithelial cell signaling in Helicobacter pylori infection	6/70	1.0638913303176253E-4	0.0015492917497750417	0	0	8.846142344497608	80.92811160391791	CDC42;TJP1;PTPRZ1;ATP6V1B2;ATP6V1H;ATP6V0A1
Proteasome	5/46	1.3122313113211358E-4	0.0017985287972813212	0	0	11.465737514518002	102.48777197221536	PSMA3;PSMC5;PSMC6;PSMB2;PSMC2
Spinocerebellar ataxia	8/143	1.6071596523556131E-4	0.002062179681702262	0	0	5.625335480407944	49.14221038808888	PSMA3;PSMC5;PSMC6;PSMB2;GNAQ;PSMC2;SLC25A5;SPTBN2
Gastric acid secretion	6/76	1.6816057490275956E-4	0.002062179681702262	0	0	8.085440874914559	70.26726157484957	CAMK2B;GNAQ;ATP1A3;ATP1B1;GNAI1;GNAI2
Bacterial invasion of epithelial cells	6/77	1.8075542303008316E-4	0.002105800678300469	0	0	7.971157086057012	68.69834677548832	DNM3;CDC42;ARPC3;CLTC;CTNNA2;DNM1
Insulin secretion	6/86	3.3086853344668966E-4	0.003671065156813271	0	0	7.071172248803828	56.666885505808956	CAMK2B;SNAP25;GNAQ;ATP1A3;ATP1B1;VAMP2
cGMP-PKG signaling pathway	8/167	4.5982746169110635E-4	0.004831392862933434	0	0	4.770394676875399	36.658857446815404	PPP1CC;PPP3CB;GNAQ;ATP1A3;ATP1B1;SLC25A5;GNAI1;GNAI2
Oocyte meiosis	7/129	4.966014501019592E-4	0.004831392862933434	0	0	5.42406210592686	41.264760761134	CAMK2B;PPP1CC;PPP3CB;PPP2R5E;YWHAZ;YWHAG;YWHAH
Tight junction	8/169	4.976542004738301E-4	0.004831392862933434	0	0	4.710655024454646	35.82738187215842	CDC42;TJP1;TUBA1A;ARPC3;MYH9;PPP2R2A;ARHGEF2;MYL12A
Long-term potentiation	5/67	7.703155152988852E-4	0.00699657152425395	0	0	7.574116743471582	54.29664921916343	CAMK2B;PPP1CC;PPP3CB;GNAQ;KRAS
Melanogenesis	6/101	7.807333031356339E-4	0.00699657152425395	0	0	5.950138504155125	42.57488887442107	CAMK2B;GSK3B;GNAQ;KRAS;GNAI1;GNAI2
Oxytocin signaling pathway	7/154	0.0014082856866766973	0.012152983888728536	0	0	4.4958791208791204	29.517164480936653	CAMK2B;PPP1CC;PPP3CB;GNAQ;KRAS;GNAI1;GNAI2
Hepatitis C	7/157	0.0015732939435386046	0.013092053173017674	0	0	4.405288461538461	28.434303556907295	GSK3B;CDK6;PPP2R2A;KRAS;YWHAZ;YWHAG;YWHAH
Vitamin B6 metabolism	2/6	0.0016770008542963586	0.013473834450036262	0	0	46.43427230046948	296.74974614939794	PDXK;PDXP
Sphingolipid signaling pathway	6/119	0.0018230456402012036	0.01415898780556268	0	0	4.997755853834103	31.52207935555907	PPP2R5E;GNAQ;PPP2R2A;KRAS;GNAI1;GNAI2
Hippo signaling pathway	7/163	0.0019482473649053485	0.014643278581385363	0	0	4.234559911242603	26.427147772161	PPP1CC;GSK3B;PPP2R2A;CTNNA2;YWHAZ;YWHAG;YWHAH
Vibrio cholerae infection	4/50	0.0020311501276339306	0.014789311866834557	0	0	8.134762002884813	50.42863493362163	TJP1;ATP6V1B2;ATP6V1H;ATP6V0A1
Platelet activation	6/124	0.0022446804618125003	0.01584880447279735	0	0	4.784770091638959	29.183231948918387	PPP1CC;GNAQ;TLN1;MYL12A;GNAI1;GNAI2
Regulation of actin cytoskeleton	8/218	0.0025391198599354816	0.017400439040146095	0	0	3.6024844720496896	21.52822302177382	CDC42;PPP1CC;ARPC3;PIP4K2A;MYH9;KRAS;MYL12A;PFN2
Glutathione metabolism	4/57	0.0032862801192964277	0.021877236222744793	0	0	7.057855673790575	40.35681180284473	GSS;IDH1;PGD;SRM
Insulin signaling pathway	6/137	0.003684086762621356	0.023844228213632666	0	0	4.307096679937178	24.135818118349206	PPP1CC;GSK3B;PRKAR1A;PRKAR2B;FASN;KRAS
Long-term depression	4/60	0.00395681513800241	0.023989662214955045	0	0	6.678740690589032	36.94890288297577	GNAQ;KRAS;GNAI1;GNAI2
Citrate cycle (TCA cycle)	3/30	0.004015437023104063	0.023989662214955045	0	0	10.355345911949685	57.13675073292928	ACLY;IDH1;ACO2
Pentose phosphate pathway	3/30	0.004015437023104063	0.023989662214955045	0	0	10.355345911949685	57.13675073292928	ALDOC;PGD;PFKP
Shigellosis	8/246	0.005260128268739419	0.029046851933563888	0	0	3.1741160232208827	16.656490820782075	CDC42;GSK3B;ARPC3;ARHGEF2;TLN1;UBA52;MYL12A;PFN2
Fructose and mannose metabolism	3/33	0.005270230006129268	0.029046851933563888	0	0	9.318396226415095	48.88133657887508	AKR1B1;ALDOC;PFKP
SNARE interactions in vesicular transport	3/33	0.005270230006129268	0.029046851933563888	0	0	9.318396226415095	48.88133657887508	STX1B;YKT6;VAMP2
Cell adhesion molecules	6/148	0.005360577824649129	0.029046851933563888	0	0	3.97122447604286	20.76427591890576	NFASC;CNTN1;NRXN2;NCAM1;L1CAM;NEO1
Glycolysis / Gluconeogenesis	4/67	0.005868013737836576	0.031073800020816413	0	0	5.934552019860076	30.493147096254894	ALDOC;ENO1;GAPDH;PFKP
HIF-1 signaling pathway	5/109	0.0064874805022211105	0.032972240220590254	0	0	4.505723443223443	22.699298687772437	CAMK2B;ALDOC;ENO1;GAPDH;PFKP
Renin secretion	4/69	0.006509540987756016	0.032972240220590254	0	0	5.751367116296026	28.955179149043758	PPP3CB;GNAQ;GNAI1;GNAI2
Cushing syndrome	6/155	0.006683370384783317	0.03313245318413857	0	0	3.783308178928101	18.947310048438435	CAMK2B;GSK3B;CDK6;GNAQ;GNAI1;GNAI2
Adherens junction	4/71	0.007195946287413533	0.034585397685038655	0	0	5.579118624885053	27.52869592941722	CDC42;TJP1;CTNNA2;ACP1
Aldosterone-regulated sodium reabsorption	3/37	0.007273323976681949	0.034585397685038655	0	0	8.220449500554938	40.47372733644185	ATP1A3;KRAS;ATP1B1
Cholinergic synapse	5/113	0.007531790487971474	0.03499531433824311	0	0	4.337962962962963	21.206663279094265	CAMK2B;GNAQ;KRAS;GNAI1;GNAI2
Rap1 signaling pathway	7/210	0.007768029532163737	0.03499531433824311	0	0	3.2463527851458887	15.769933708329953	CDC42;GNAQ;KRAS;TLN1;GNAI1;PFN2;GNAI2
Leukocyte transendothelial migration	5/114	0.007810113071195886	0.03499531433824311	0	0	4.297946701616427	20.855080807872714	CDC42;CTNNA2;MYL12A;GNAI1;GNAI2
Growth hormone synthesis, secretion and action	5/119	0.009309580806230318	0.04092702505380499	0	0	4.108395989974937	19.21378160152699	GSK3B;GNAQ;KRAS;GNAI1;GNAI2
Ferroptosis	3/41	0.009670639415106472	0.041446103234610704	0	0	7.3536494538232375	34.111085812204124	FTH1;GSS;SLC3A2
Human papillomavirus infection	9/331	0.009819010871272281	0.041446103234610704	0	0	2.640761623349213	12.209389419303612	CDC42;GSK3B;CDK6;PPP2R5E;ATP6V1B2;ATP6V1H;PPP2R2A;KRAS;ATP6V0A1
Thyroid hormone signaling pathway	5/121	0.009961295198018024	0.041446103234610704	0	0	4.037151067323481	18.607423762593	GSK3B;ATP1A3;KRAS;ATP1B1;PFKP
Cell cycle	5/124	0.010996583490399272	0.04381299699768478	0	0	3.9347739095638254	17.746501786384847	GSK3B;CDK6;YWHAZ;YWHAG;YWHAH
Thiamine metabolism	2/15	0.011014757657085695	0.04381299699768478	0	0	14.280967858432648	64.38601921445527	AK1;ACP1
Human cytomegalovirus infection	7/225	0.011094278209714172	0.04381299699768478	0	0	3.0206642554693013	13.596993886381725	GSK3B;PPP3CB;CDK6;GNAQ;KRAS;GNAI1;GNAI2
Cardiac muscle contraction	4/87	0.014443856213996591	0.05609030829768676	0	0	4.499971449780164	19.0685666053622	ACTC1;TPM1;ATP1A3;ATP1B1
GABAergic synapse	4/89	0.015584989359734302	0.05952954952160807	0	0	4.393643713409534	18.2839156632753	NSF;GPHN;GNAI1;GNAI2
Cysteine and methionine metabolism	3/50	0.016574156104610556	0.062286747941520317	0	0	5.942794058611	24.364924698932942	AHCYL2;GSS;SRM
Chemokine signaling pathway	6/192	0.01781433146309702	0.06464394460007925	0	0	3.0250038586201575	12.183965363520207	CDC42;GSK3B;GNAQ;KRAS;GNAI1;GNAI2
GnRH signaling pathway	4/93	0.018033718450665884	0.06464394460007925	0	0	4.195324564673306	16.84637624311684	CAMK2B;CDC42;GNAQ;KRAS
Salivary secretion	4/93	0.018033718450665884	0.06464394460007925	0	0	4.195324564673306	16.84637624311684	GNAQ;ATP1A3;ATP1B1;VAMP2
Apoptosis	5/142	0.018773937514499354	0.06627768849815681	0	0	3.4146680570038233	13.574281006330647	TUBA1A;PARP1;DIABLO;KRAS;SPTAN1
Endocytosis	7/252	0.019507502603599375	0.0678395239796814	0	0	2.684065934065934	10.567049855277821	DNM3;CDC42;KIF5C;ARPC3;CLTC;AMPH;DNM1
Circadian entrainment	4/97	0.020709134374089947	0.07095923984063172	0	0	4.0140651276563215	15.563254645031678	CAMK2B;GNAQ;GNAI1;GNAI2
Aldosterone synthesis and secretion	4/98	0.021414006173371997	0.07127804911993822	0	0	3.971160633256025	15.263990143270545	CAMK2B;GNAQ;ATP1A3;ATP1B1
mRNA surveillance pathway	4/98	0.021414006173371997	0.07127804911993822	0	0	3.971160633256025	15.263990143270545	PPP1CC;DDX39B;PPP2R5E;PPP2R2A
Diabetic cardiomyopathy	6/203	0.022715406531061143	0.07350957946857287	0	0	2.854492021470381	10.803429873301718	CAMK2B;PPP1CC;GSK3B;PARP1;SLC25A5;GAPDH
Viral carcinogenesis	6/203	0.022715406531061143	0.07350957946857287	0	0	2.854492021470381	10.803429873301718	CDC42;CDK6;KRAS;YWHAZ;YWHAG;YWHAH
Chagas disease	4/102	0.024379636941661436	0.07720335439042621	0	0	3.8082986749202052	14.144048114539611	GNAQ;PPP2R2A;GNAI1;GNAI2
Endometrial cancer	3/58	0.02451952027850446	0.07720335439042621	0	0	5.0763293310463125	18.824479632316727	GSK3B;KRAS;CTNNA2
Proximal tubule bicarbonate reclamation	2/23	0.025090238576642023	0.07752023676792755	0	0	8.83702213279678	32.56686919901022	ATP1A3;ATP1B1
mTOR signaling pathway	5/154	0.025583486098705064	0.07752023676792755	0	0	3.1377436880792584	11.502366572372678	GSK3B;ATP6V1B2;ATP6V1H;SLC3A2;KRAS
VEGF signaling pathway	3/59	0.025633574181627594	0.07752023676792755	0	0	4.985427897574124	18.265871445482606	CDC42;PPP3CB;KRAS
T cell receptor signaling pathway	4/104	0.02595098054891995	0.07752023676792755	0	0	3.7317535545023697	13.626669332040155	CDC42;GSK3B;PPP3CB;KRAS
Mineral absorption	3/60	0.026774458336385604	0.07821035631709689	0	0	4.897715988083416	17.731234951875788	FTH1;ATP1A3;ATP1B1
Cellular senescence	5/156	0.026853341224754294	0.07821035631709689	0	0	3.095868811100599	11.198887560405382	PPP1CC;PPP3CB;CDK6;KRAS;SLC25A5
Parathyroid hormone synthesis, secretion and action	4/106	0.02758190750565145	0.07934054875082454	0	0	3.658210203512685	13.13515216694444	NACA;GNAQ;GNAI1;GNAI2
Glucagon signaling pathway	4/107	0.028419829183033905	0.08075390487374268	0	0	3.622509547692449	12.898554430326712	CAMK2B;PPP3CB;GNAQ;PFKP
Necroptosis	5/159	0.028832391265526322	0.08093912246828473	0	0	3.035095856524428	10.76322636706176	CAMK2B;PARP1;FTH1;SLC25A5;PPIA
cAMP signaling pathway	6/216	0.029589437235996604	0.08207546280937153	0	0	2.6760082023239917	9.420452911974628	CAMK2B;PPP1CC;ATP1A3;ATP1B1;GNAI1;GNAI2
Folate biosynthesis	2/26	0.03156182748740934	0.0865165388772515	0	0	7.731220657276995	26.717605534374844	AKR1B1;GPHN
Serotonergic synapse	4/113	0.033764117357249476	0.0906552379326258	0	0	3.4220618287751643	11.595165978389904	GNAQ;KRAS;GNAI1;GNAI2
Collecting duct acid secretion	2/27	0.03384980987183882	0.0906552379326258	0	0	7.421596244131456	25.128203069800627	ATP6V1B2;ATP6V0A1
Glutamatergic synapse	4/114	0.03470790063488087	0.09189705509008231	0	0	3.3907798362774666	11.39569196041874	PPP3CB;GNAQ;GNAI1;GNAI2
Butanoate metabolism	2/28	0.036200453498927185	0.09477197376685431	0	0	7.135789093535572	23.681426470646194	ALDH5A1;ACAT2
PI3K-Akt signaling pathway	8/354	0.038075521078198095	0.0979129286817268	0	0	2.1712881516852365	7.0961685338794505	GSK3B;CDK6;PPP2R5E;PPP2R2A;KRAS;YWHAZ;YWHAG;YWHAH
Amphetamine addiction	3/69	0.038240671716897594	0.0979129286817268	0	0	4.227915951972555	13.799307262442618	CAMK2B;PPP1CC;PPP3CB
Central carbon metabolism in cancer	3/70	0.0396463581590296	0.09935180290508783	0	0	4.164601520698395	13.442318315782247	IDH1;KRAS;PFKP
Neurotrophin signaling pathway	4/119	0.039655440644520035	0.09935180290508783	0	0	3.242530393570987	10.465354794201799	CAMK2B;CDC42;GSK3B;KRAS
AMPK signaling pathway	4/120	0.04069074524396774	0.1007623444773742	0	0	3.214414119954241	10.291765201212478	PPP2R5E;FASN;PPP2R2A;PFKP
Glyoxylate and dicarboxylate metabolism	2/30	0.04108335933626845	0.1007623444773742	0	0	6.62541918175721	21.149345898835282	ACO2;ACAT2
Non-small cell lung cancer	3/72	0.04253545992332784	0.10323710585557695	0	0	4.043478260869565	12.766947807854862	CDK6;KIF5C;KRAS
Galactose metabolism	2/31	0.043612505649984624	0.10475993625202491	0	0	6.396632669580702	20.03688473068462	AKR1B1;PFKP
Glioma	3/75	0.047061456031831386	0.11076080055976477	0	0	3.8744103773584904	11.841364141259115	CAMK2B;CDK6;KRAS
Thyroid hormone synthesis	3/75	0.047061456031831386	0.11076080055976477	0	0	3.8744103773584904	11.841364141259115	GNAQ;ATP1A3;ATP1B1
Pancreatic cancer	3/76	0.04862084151211245	0.113286560723222	0	0	3.8211424140604806	11.553999789620127	CDC42;CDK6;KRAS
Pentose and glucuronate interconversions	2/34	0.05153257017958881	0.1188820678400415	0	0	5.796068075117371	17.188478909742603	DCXR;AKR1B1
RNA degradation	3/79	0.053448974167667196	0.1220942253045731	0	0	3.6697492552135054	10.748797712571342	ENO1;LSM5;PFKP
B cell receptor signaling pathway	3/81	0.056791027966046445	0.12787036781319644	0	0	3.575290275761974	10.255280123869026	GSK3B;PPP3CB;KRAS
Tyrosine metabolism	2/36	0.05707518563335806	0.12787036781319644	0	0	5.454570560618613	15.61854007451344	MIF;COMT
Kaposi sarcoma-associated herpesvirus infection	5/193	0.057737609835728315	0.1281225056354733	0	0	2.481889564336373	7.07796806966817	GSK3B;PPP3CB;CDK6;KRAS;UBA52
Apelin signaling pathway	4/137	0.06061918415427922	0.13078027692543573	0	0	2.8011260378434235	7.851959270319095	GNAQ;KRAS;GNAI1;GNAI2
Estrogen signaling pathway	4/137	0.06061918415427922	0.13078027692543573	0	0	2.8011260378434235	7.851959270319095	GNAQ;KRAS;GNAI1;GNAI2
Yersinia infection	4/137	0.06061918415427922	0.13078027692543573	0	0	2.8011260378434235	7.851959270319095	CDC42;GSK3B;ARPC3;GNAQ
Pathways in cancer	10/531	0.061669970413227006	0.13182663400258615	0	0	1.8036608772997518	5.0249237565508205	CAMK2B;CDC42;GSK3B;CDK6;DCC;GNAQ;KRAS;CTNNA2;GNAI1;GNAI2
ErbB signaling pathway	3/85	0.06376455816405864	0.13506492774750603	0	0	3.4001955821445007	9.359234727182095	CAMK2B;GSK3B;KRAS
Colorectal cancer	3/86	0.06556711919238857	0.1376318808272661	0	0	3.359058877017504	9.15236370027429	GSK3B;DCC;KRAS
Focal adhesion	5/201	0.06630674365279995	0.1379417077776999	0	0	2.3796161321671527	6.457001929707943	CDC42;PPP1CC;GSK3B;TLN1;MYL12A
Proteoglycans in cancer	5/205	0.07084381878331665	0.14607619271250247	0	0	2.331547619047619	6.172253692813215	CAMK2B;CDC42;PPP1CC;ANK2;KRAS
Hypertrophic cardiomyopathy	3/90	0.07300799662651855	0.14921809836823527	0	0	3.2039687703318154	8.385383174557386	ACTC1;TPM1;EMD
Spliceosome	4/150	0.07876745625530326	0.1576930165066691	0	0	2.5500227228461987	6.4802589102770805	EFTUD2;DDX39B;SNRPA1;LSM5
Rheumatoid arthritis	3/93	0.07882484509767285	0.1576930165066691	0	0	3.0966981132075473	7.867245287279743	ATP6V1B2;ATP6V1H;ATP6V0A1
Human immunodeficiency virus 1 infection	5/212	0.07918490528446473	0.1576930165066691	0	0	2.251897860593513	5.710744490127817	PPP3CB;GNAQ;KRAS;GNAI1;GNAI2
Vasopressin-regulated water reabsorption	2/44	0.08110759237575375	0.16015312731822565	0	0	4.413816230717639	11.08741237840029	NSF;VAMP2
Riboflavin metabolism	1/8	0.08284655391141456	0.1609922035188985	0	0	13.202937249666222	32.88541571880503	ACP1
Lipid and atherosclerosis	5/215	0.08291443958054859	0.1609922035188985	0	0	2.2193877551020407	5.526155777125069	CAMK2B;CDC42;GSK3B;PPP3CB;KRAS
Dilated cardiomyopathy	3/96	0.08483748464915504	0.1633647431673812	0	0	2.9963481436396835	7.392044199052864	ACTC1;TPM1;EMD
Fc gamma R-mediated phagocytosis	3/97	0.08688413578626623	0.16593445605081994	0	0	2.9643215576073865	7.242370611008931	CDC42;ARPC3;AMPH
Inflammatory mediator regulation of TRP channels	3/98	0.0889516152054462	0.16850184018592654	0	0	2.932969215491559	7.096796229914039	CAMK2B;PPP1CC;GNAQ
Carbohydrate digestion and absorption	2/47	0.09079595478538531	0.16852655922659063	0	0	4.118935837245696	9.881905970168374	ATP1A3;ATP1B1
Pyruvate metabolism	2/47	0.09079595478538531	0.16852655922659063	0	0	4.118935837245696	9.881905970168374	ACYP1;ACAT2
Ribosome	4/158	0.09113453417403612	0.16852655922659063	0	0	2.4165692127777434	5.788694518351605	RPLP1;RPLP2;RPS10;UBA52
Progesterone-mediated oocyte maturation	3/100	0.09314810590825737	0.17089376910727533	0	0	2.87220385139078	6.817361144157757	KRAS;GNAI1;GNAI2
Pancreatic secretion	3/102	0.09742503120017974	0.17598493713723287	0	0	2.813893653516295	6.552635664440629	GNAQ;ATP1A3;ATP1B1
Cocaine addiction	2/49	0.09743372056095725	0.17598493713723287	0	0	3.9432624113475176	9.18221350510291	GNAI1;GNAI2
Protein digestion and absorption	3/103	0.09959304710065953	0.1785013844188744	0	0	2.78561320754717	6.425470709391487	ATP1A3;SLC3A2;ATP1B1
Synthesis and degradation of ketone bodies	1/10	0.10246762456232947	0.18225157651162416	0	0	10.26791277258567	23.39244500807539	ACAT2
Regulation of lipolysis in adipocytes	2/55	0.11810829981587277	0.20847904437195725	0	0	3.4957923642483832	7.467548326427223	GNAI1;GNAI2
Tuberculosis	4/180	0.12948336850532746	0.2268392846747466	0	0	2.11212839293408	4.317618847918254	CAMK2B;PPP3CB;ATP6V1H;ATP6V0A1
Alcoholism	4/186	0.14095048654975464	0.24508554750815548	0	0	2.041872819124004	4.000736585173482	PPP1CC;KRAS;GNAI1;GNAI2
GnRH secretion	2/64	0.15087478633034448	0.260398705296076	0	0	2.9869756171437225	5.649281966682518	GNAQ;KRAS
Lysosome	3/128	0.15943059008202634	0.2731421138905304	0	0	2.2256603773584906	4.086638786658597	CLTC;ATP6V1H;ATP6V0A1
Relaxin signaling pathway	3/129	0.1620195283542941	0.2755514606317557	0	0	2.2078840970350404	4.018433851756746	KRAS;GNAI1;GNAI2
Mitophagy	2/68	0.1659623462835603	0.28021178756572135	0	0	2.8053777208706787	5.038442525000758	KRAS;UBA52
Phenylalanine metabolism	1/17	0.16790847553768617	0.2808980814685324	0	0	5.773656542056075	10.302144585073925	MIF
Renal cell carcinoma	2/69	0.16977493518530917	0.2808980814685324	0	0	2.763366267255273	4.900226637996051	CDC42;KRAS
Oxidative phosphorylation	3/133	0.1724998766627379	0.2808980814685324	0	0	2.139513788098694	3.7598932923277766	ATP6V1B2;ATP6V1H;ATP6V0A1
Vascular smooth muscle contraction	3/133	0.1724998766627379	0.2808980814685324	0	0	2.139513788098694	3.7598932923277766	PPP1CC;GNAQ;MYH9
Epstein-Barr virus infection	4/202	0.17336240450097576	0.2808980814685324	0	0	1.8753410886112307	3.2862934360516616	PSMC5;PSMC6;CDK6;PSMC2
Prolactin signaling pathway	2/70	0.17360224777454364	0.2808980814685324	0	0	2.7225904446285556	4.767224637245866	GSK3B;KRAS
Fatty acid biosynthesis	1/18	0.17686105623079498	0.28419742139155335	0	0	5.4337548103353495	9.413387102196012	FASN
Melanoma	2/72	0.1812980496681482	0.28933181899094884	0	0	2.6445338698859824	4.515840200324165	CDK6;KRAS
Chronic myeloid leukemia	2/76	0.19683418847559772	0.3098808507757721	0	0	2.5010785433320644	4.065237026223405	CDK6;KRAS
Pertussis	2/76	0.19683418847559772	0.3098808507757721	0	0	2.5010785433320644	4.065237026223405	GNAI1;GNAI2
Arrhythmogenic right ventricular cardiomyopathy	2/77	0.20074429242994132	0.31391557138373377	0	0	2.4676056338028167	3.962292004017821	CTNNA2;EMD
Pantothenate and CoA biosynthesis	1/21	0.20314760340500082	0.3155559439557679	0	0	4.617990654205608	7.360257196054018	AASDHPPT
Human T-cell leukemia virus 1 infection	4/219	0.21029201199778313	0.32069449333216277	0	0	1.7255593519232888	2.6905925360079896	PPP3CB;KRAS;TLN1;SLC25A5
Breast cancer	3/147	0.21054993975292077	0.32069449333216277	0	0	1.930129716981132	3.0072046555560537	GSK3B;CDK6;KRAS
Terpenoid backbone biosynthesis	1/22	0.21172275831876539	0.32069449333216277	0	0	4.397863818424566	6.827585083249908	ACAT2
Phospholipase D signaling pathway	3/148	0.21333753848276923	0.32069449333216277	0	0	1.9167208848405985	2.961103146939758	DNM3;KRAS;DNM1
Retrograde endocannabinoid signaling	3/148	0.21333753848276923	0.32069449333216277	0	0	1.9167208848405985	2.961103146939758	GNAQ;GNAI1;GNAI2
Gastric cancer	3/149	0.21613314691183727	0.3228142514772954	0	0	1.9034957353321271	2.91589019597065	GSK3B;KRAS;CTNNA2
Protein export	1/23	0.220206058125105	0.3250476203780081	0	0	4.197748513169074	6.3519975504002195	SRP14
Peroxisome	2/82	0.22041855802457203	0.3250476203780081	0	0	2.312793427230047	3.497468674601846	IDH1;ECH1
Coronavirus disease	4/232	0.23990266539024	0.3515554782133705	0	0	1.6260912945871788	2.321281095041667	RPLP1;RPLP2;RPS10;UBA52
PD-L1 expression and PD-1 checkpoint pathway in cancer	2/89	0.24819971931638324	0.3614408412544831	0	0	2.125951108952566	2.9625586571237488	PPP3CB;KRAS
Bile secretion	2/90	0.252181349770881	0.36495810246344895	0	0	2.1016858728126335	2.895296767380521	ATP1A3;ATP1B1
Morphine addiction	2/91	0.2561646430276198	0.36843433225577416	0	0	2.0779659228780925	2.830054320521004	GNAI1;GNAI2
Calcium signaling pathway	4/240	0.25858588140481353	0.3696350329283531	0	0	1.5703269338902723	2.123910221382106	CAMK2B;PPP3CB;GNAQ;SLC25A5
Wnt signaling pathway	3/166	0.26466065409822476	0.3760117829566242	0	0	1.7034957749739552	2.2644685586247317	CAMK2B;GSK3B;PPP3CB
Hepatocellular carcinoma	3/168	0.2704660466882804	0.38193084168708685	0	0	1.6826758147512864	2.200281550019364	GSK3B;CDK6;KRAS
Protein processing in endoplasmic reticulum	3/171	0.2792004143265003	0.39075969844396136	0	0	1.6523753369272238	2.1081424650366114	DNAJB2;RAD23A;CKAP4
Prostate cancer	2/97	0.2800724018890195	0.39075969844396136	0	0	1.9461329379787498	2.476857268162905	GSK3B;KRAS
AGE-RAGE signaling pathway in diabetic complications	2/100	0.2920110215935288	0.4049914763767394	0	0	1.8862700009581297	2.3219299603971795	CDC42;KRAS
Base excision repair	1/33	0.3001974283244959	0.4138816615361393	0	0	2.8844918224299065	3.4709520648936163	PARP1
Propanoate metabolism	1/34	0.307732727408798	0.4195197186147997	0	0	2.796941376380629	3.2962615342495463	ACAT2
C-type lectin receptor signaling pathway	2/104	0.3078878621593594	0.4195197186147997	0	0	1.811930405965203	2.1344896157766517	PPP3CB;KRAS
Starch and sucrose metabolism	1/36	0.322561892259091	0.4334537240151853	0	0	2.636849132176235	2.9834899708625975	PGM2L1
RNA transport	3/186	0.3231677324984887	0.4334537240151853	0	0	1.515774822146613	1.712194675792804	DDX39B;EEF1A2;EIF4G2
Insulin resistance	2/108	0.3236950557023272	0.4334537240151853	0	0	1.7432013464434406	1.9662498725096291	PPP1CC;GSK3B
African trypanosomiasis	1/37	0.32985747217299294	0.4342191582842223	0	0	2.563473520249221	2.8431346906525783	GNAQ
Alanine, aspartate and glutamate metabolism	1/37	0.32985747217299294	0.4342191582842223	0	0	2.563473520249221	2.8431346906525783	ALDH5A1
Thyroid cancer	1/37	0.32985747217299294	0.4342191582842223	0	0	2.563473520249221	2.8431346906525783	KRAS
Toxoplasmosis	2/112	0.33941014168074707	0.44428406186300035	0	0	1.6794707639778061	1.8147454924216488	GNAI1;GNAI2
Bladder cancer	1/41	0.35826601847217937	0.466346269854848	0	0	2.306658878504673	2.3677380526517173	KRAS
Tryptophan metabolism	1/42	0.3651788181429163	0.47270369237388615	0	0	2.2502849327558696	2.2668653306348214	ACAT2
Fat digestion and absorption	1/43	0.37201749513677845	0.4762641558619196	0	0	2.196595460614152	2.1720252133739733	ACAT2
Fatty acid degradation	1/43	0.37201749513677845	0.4762641558619196	0	0	2.196595460614152	2.1720252133739733	ACAT2
MAPK signaling pathway	4/294	0.3891135262481716	0.4954286973542294	0	0	1.274391240398758	1.2028776757441435	CDC42;PPP3CB;KRAS;MAPT
Osteoclast differentiation	2/127	0.3971938130262546	0.5020793238261343	0	0	1.4768075117370891	1.363582043499342	PPP3CB;SIRPA
Nucleotide excision repair	1/47	0.3986466734241839	0.5020793238261343	0	0	2.005180820804551	1.8441242655039944	RAD23A
Valine, leucine and isoleucine degradation	1/48	0.4051264370854153	0.5074970959188266	0	0	1.9624179757407039	1.7731546743727635	ACAT2
Ether lipid metabolism	1/49	0.411536700451846	0.5108931180124785	0	0	1.9214369158878504	1.7059613615486515	PLD3
Natural killer cell mediated cytotoxicity	2/131	0.41222277333195695	0.5108931180124785	0	0	1.4307238781526368	1.2678951447925606	PPP3CB;KRAS
Arginine and proline metabolism	1/50	0.41787820546444665	0.5151620204932067	0	0	1.8821285523555216	1.6422799960427914	SRM
Measles	2/139	0.4417114111900173	0.5416776779330212	0	0	1.3466296562831979	1.100329107225658	GSK3B;CDK6
Hedgehog signaling pathway	1/56	0.45452387989487475	0.5535570113179316	0	0	1.6762956669498725	1.3217672227268664	GSK3B
Signaling pathways regulating pluripotency of stem cells	2/143	0.4561499835752912	0.5535570113179316	0	0	1.3081610228748377	1.0268195570216567	GSK3B;KRAS
Legionellosis	1/57	0.46040420074632216	0.5558247604864925	0	0	1.6462783711615487	1.276936605599493	EEF1A2
Chemical carcinogenesis	3/239	0.4754534889938011	0.5707535212721718	0	0	1.1721897985289416	0.8715069585925946	KRAS;GNAI1;GNAI2
Viral myocarditis	1/60	0.4776692560003155	0.5707535212721718	0	0	1.5623316964992873	1.1543080246946258	EIF4G2
Glycerolipid metabolism	1/61	0.48330119480753325	0.5716201948738846	0	0	1.536214953271028	1.1170052859249018	AKR1B1
Steroid hormone biosynthesis	1/61	0.48330119480753325	0.5716201948738846	0	0	1.536214953271028	1.1170052859249018	COMT
Basal cell carcinoma	1/63	0.4943843796733678	0.5788520626326367	0	0	1.4865088935785349	1.0471592502183498	GSK3B
Lysine degradation	1/63	0.4943843796733678	0.5788520626326367	0	0	1.4865088935785349	1.0471592502183498	ACAT2
Non-alcoholic fatty liver disease	2/155	0.49814096933678514	0.5803342292773547	0	0	1.2048237135229678	0.8396081169838383	CDC42;GSK3B
Cortisol synthesis and secretion	1/65	0.505230911728173	0.5856656837445986	0	0	1.4399094626168225	0.9830833592387263	GNAQ
Aminoacyl-tRNA biosynthesis	1/66	0.5105670089696963	0.5889213519303922	0	0	1.4176851186196981	0.9530152711759711	FARSA
Acute myeloid leukemia	1/67	0.5158458208903408	0.5920791934357114	0	0	1.3961342395921834	0.9241673669461691	KRAS
Fc epsilon RI signaling pathway	1/68	0.5210679595951159	0.5929186901515915	0	0	1.3752266703863858	0.8964756176629279	KRAS
Hepatitis B	2/162	0.5216666587170655	0.5929186901515915	0	0	1.1517018779342723	0.7494429089394858	KRAS;YWHAZ
Inositol phosphate metabolism	1/73	0.5463495284279274	0.614973140694237	0	0	1.2794003115264798	0.7733928135138628	PIP4K2A
p53 signaling pathway	1/73	0.5463495284279274	0.614973140694237	0	0	1.2794003115264798	0.7733928135138628	CDK6
PPAR signaling pathway	1/74	0.5512441231286235	0.6174994263892754	0	0	1.2618102675713736	0.7515058213775376	FABP3
Influenza A	2/172	0.5539771471357255	0.6175917477637514	0	0	1.0834023750345207	0.6398919422824226	CDK6;SLC25A5
Leishmaniasis	1/77	0.5656147488048877	0.6275630308168516	0	0	1.211817511067388	0.6905446212082227	EEF1A2
NOD-like receptor signaling pathway	2/181	0.5817192414530852	0.6423724325050656	0	0	1.0284575235397488	0.5571847077801099	TP53BP1;SUGT1
Small cell lung cancer	1/92	0.6308799858079964	0.6901175431608599	0	0	1.0112971141008524	0.46584352982310506	CDK6
Th1 and Th2 cell differentiation	1/92	0.6308799858079964	0.6901175431608599	0	0	1.0112971141008524	0.46584352982310506	PPP3CB
IL-17 signaling pathway	1/94	0.6388098590731948	0.692291614716532	0	0	0.9894482966536027	0.44341969974207335	GSK3B
TGF-beta signaling pathway	1/94	0.6388098590731948	0.692291614716532	0	0	0.9894482966536027	0.44341969974207335	NEO1
Phosphatidylinositol signaling system	1/97	0.6503878294810889	0.6959831954232809	0	0	0.9583820093457944	0.4122829383236027	PIP4K2A
MicroRNAs in cancer	3/310	0.6505416637657386	0.6959831954232809	0	0	0.8978243500706778	0.386019520278973	CDK6;TPM1;KRAS
Choline metabolism in cancer	1/98	0.6541644626510665	0.6959831954232809	0	0	0.9484536082474226	0.4025203796078004	KRAS
Glycerophospholipid metabolism	1/98	0.6541644626510665	0.6959831954232809	0	0	0.9484536082474226	0.4025203796078004	PLD3
Amoebiasis	1/102	0.6688692284260657	0.7051879195623226	0	0	0.9107060238734154	0.3662556464602094	GNAQ
Longevity regulating pathway	1/102	0.6688692284260657	0.7051879195623226	0	0	0.9107060238734154	0.3662556464602094	KRAS
NF-kappa B signaling pathway	1/104	0.675986523600919	0.7094813513469105	0	0	0.8929316758914799	0.34965609530452674	PARP1
Th17 cell differentiation	1/107	0.6863779519561265	0.7171572323129034	0	0	0.8675277728795627	0.3264739963111339	PPP3CB
Ras signaling pathway	2/232	0.7149167647145276	0.7436410990110934	0	0	0.798326189018167	0.26790961202627467	CDC42;KRAS
Purine metabolism	1/129	0.7530967513658002	0.7798735247476953	0	0	0.7176182827102804	0.20348896803019018	AK1
FoxO signaling pathway	1/131	0.7584108291694482	0.7819014300729267	0	0	0.7065061107117182	0.19537016953763006	KRAS
Autophagy	1/137	0.7736795948301367	0.7941292757507571	0	0	0.6751305662451896	0.17323678256985184	KRAS
Fluid shear stress and atherosclerosis	1/139	0.7785526175566847	0.7945908656538112	0	0	0.6652783421373425	0.16653161081201448	ARHGEF2
Ubiquitin mediated proteolysis	1/140	0.7809498207498831	0.7945908656538112	0	0	0.6604585490486116	0.16329466527221242	UBA52
Neutrophil extracellular trap formation	1/189	0.871580576761107	0.8829490190666865	0	0	0.4870998210379797	0.06695038997807867	SLC25A5
Thermogenesis	1/232	0.9197136963280492	0.9276765854737465	0	0	0.39555771331472267	0.03310535514168216	KRAS
Olfactory transduction	1/440	0.9918405626175941	0.9957048887302892	0	0	0.20592680901794647	0.00168713935620063	CAMK2B
Herpes simplex virus 1 infection	1/498	0.9957048887302892	0.9957048887302892	0	0	0.18134978092856202	7.805950617670258E-4	PPP1CC
